The aim of our study was to evaluate the outcomes of patients reirradiated with high-dose-rate (HDR) intensity-modulated brachytherapy (IMBT) for recurrent head and neck cancer and to perform a systematic review of the literature.
Materials and Methods
Patients treated with prior radiation doses >65 Gy were considered. After resection of macroscopic disease, catheters were fixed to the tumor bed. The total dose was 30 Gy in 12 fractions of 2.5 Gy twice daily for 5 days a week. A systematic literature search was conducted through several electronic databases including Medline/PubMed, Scopus, Embase and the Cochrane library.
Results
Seventeen patients were included; median overall survival was 19 months with a median local control interval of 15 months. Median follow-up was 36 months. Seven papers were considered for the review.
Conclusions
IMBT could play an important role in the retreatment of recurrent head and neck cancer.
HongWKBromerRHAmatoDAPatterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer.1985;56 (6):1242–1245.
2.
VokesEEWeichselbaumRRLippmanSMHongWKHead and neck cancer. N Engl J Med.1993;328 (3):184–194.
3.
PignonJPle MaîtreAMaillardEBourhisJMACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol.2009;92 (1):4–14.
4.
BrocksteinBHarafDJRademakerAWPatterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol.2004;15 (8):1179–1186.
5.
ChmuraSJMilanoMTHarafDJReirradiation of recurrent head and neck cancers with curative intent. Semin Oncol.2004;31 (6):816–821.
6.
KaspertsNSlotmanBLeemansCRLangendijkJAA review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol.2005;41 (3):225–243.
7.
PradhanSARajpalRMKotharyPMSurgical management of postradiation residual/recurrent cancer of the base of the tongue. J Surg Oncol.1980;14 (3):201–206.
8.
MabantaSRMendenhallWMStringerSPCassisiNJSalvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck.1999;21 (7):591–594.
9.
KaoJGarofaloMCMilanoMTChmuraSJCitronJRHarafDJReirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev.2003;29 (1):21–30.
10.
WongSJMachtayMLiYLocally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?J Clin Oncol.2006;24 (17):2653–2658.
11.
JanotFde RaucourtDBenhamouERandomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol.2008;26 (34):5518–5523.
12.
QiXSYangQLeeSPLiXAWangDAn Estimation of radiobiological parameters for head-and-neck cancer cells and the clinical implications. Cancers (Basel).2012;4 (2):566–580.
13.
MazeronJJArdietJMHaie-MéderCGEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol.2009;91 (2):150–156.
14.
GerbauletAPötterRMazeronJJMeertensAvan LimbergenEThe GEC ESTRO handbook of brachytherapy. Brussels, Belgium: ESTRO2002.
15.
KovácsGModern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy. J Contemp Brachytherapy.2015;6 (4):404–416.
16.
TeudtIUMeyerJERitterMPerioperative image-adapted brachytherapy for the treatment of paranasal sinus and nasal cavity malignancies. Brachytherapy.2014;13 (2):178–186.
17.
StregeRJKovácsGMeyerJEHollandDClaviezAMehdornMHInterdisciplinary Group of Orbitazentrum UK S-H. Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children. Strahlenther Onkol.2009;185 (12):789–798.
18.
ValentiniVMauriziFTagliaferriLSPIDER: managing clinical data of cancer patients treated through a multidisciplinary approach by a palm based system. Ital J Public Health.2008;5 (2):154–164.
19.
TagliaferriLKovácsGAutorinoRENT COBRA (Consortium for Brachytherapy Data Analysis): interdisciplinary standardized data collection system for head and neck patients treated with interventional radiotherapy (brachytherapy). J Contemp Brachytherapy.2016;8 (4):336–343.
20.
TagliaferriLBussuFRiganteMEndoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences. Brachytherapy.2015;14 (3):419–425.
21.
BentzenSMConstineLSDeasyJOQuantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys.2010;76 (3 Suppl):S3–S9.
22.
US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Published May 28, 2009.
23.
NiederCLangedijkJARe-irradiation: new frontiers. Berlin, Heidelberg: Springer-Verlag2011.
24.
OksuzDCPrestwichRJCareyBRecurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy. Radiat Oncol.2011;6 (1):54.
25.
LangendijkJABourhisJReirradiation in squamous cell head and neck cancer: recent developments and future directions. Curr Opin Oncol.2007;19 (3):202–209.
26.
SalamaJKVokesEEConcurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer. Semin Oncol.2008;35 (3):251–261.
27.
HoASKrausDHGanlyILeeNYShahJPMorrisLGDecision making in the management of recurrent head and neck cancer. Head Neck.2014;36 (1):144–151.
28.
CacicedoJNavarroAAlongiFThe role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach. Cancer Treat Rev.2014;40 (1):178–189.
29.
ChenAMPhillipsTLLeeNYPractical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much?Int J Radiat Oncol Biol Phys.2011;81 (5):1211–1219.
30.
StregeRJKovácsGMauneSFeasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base. Strahlenther Onkol.2005;181 (2):97–107.
31.
TanvetyanonTQinDPadhyaTKapoorRMcCaffreyJTrottiASurvival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled analysis. Am J Otolaryngol.2009;30 (1):38–43.
32.
Martínez-MongeRCambeiroMRodríguez-RuizMEA proposal for the stratification of the risk of locoregional failure after surgical resection, perioperative high dose rate brachytherapy, and external beam irradiation: the University of Navarre predictive model. Brachytherapy.2014;13 (4):400–404.
33.
McDonaldMWLawsonJGargMKet al;Expert Panel on Radiation Oncology-Head and Neck Cancer. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int J Radiat Oncol Biol Phys.2011;80 (5):1292–1298.
34.
DonathDVuongTShenoudaGMacDonaldBTabahRThe potential uses of high-dose-rate brachytherapy in patients with head and neck cancer. Eur Arch Otorhinolaryngol.1995;252 (6):321–324.
35.
CornesPGCoxHJRhys-EvansPRBreachNMHenkJMSalvage treatment for inoperable neck nodes in head and neck cancer using combined iridium-192 brachytherapy and surgical reconstruction. Br J Surg.1996;83 (11):1620–1622.
36.
Martínez-MongeRAlcaldeJConcejoCCambeiroMGarránCPerioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: initial results of a phase I/II reirradiation study. Brachytherapy.2006;5 (1):32–40.
37.
NarayanaACohenGNZaiderMHigh-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancerspreliminary results. Brachytherapy.2007;6 (2):157–163.
38.
SchiefkeFHildebrandtGPohlmannSHeinickeFHemprichAFrerichBCombination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas. J Craniomaxillofac Surg.2008;36 (5):285–292.
39.
RudzianskasVInciuraAJuozaityteEReirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy. Acta Otorhinolaryngol Ital.2012;32 (5):297–303.
40.
TeudtIUKovàcsGRitterMIntensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases. Eur Arch Otorhinolaryngol.2016;273 (9):2707–2715.
